NCT01259856 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 168
- units
- Participants
- groups
- description
- The subject received the PEGASYS at a dose level of 45 micrograms weekly and gradually increased to the maximum dose of 180 micrograms per week. The dose was administered by prefilled syringes and injected subcutaneously. Subjects received therapy for up to 12 months. Aspirin: Subject asked to take 81 to 100mg per day for the 12 months of the study treatment.
- id
- BG000
- title
- PEGASYS
- description
- Subjects received a 500mg tablet to be taken twice daily for up to 12 months of treatment. Aspirin: Subject asked to take 81 to 100mg per day for the 12 months of the study treatment.
- id
- BG001
- title
- Hydroxyurea
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 14.8
- value
- 56.8
- group Id
- BG001
- spread
- 12.8
- value
- 61.8
- group Id
- BG002
- spread
- 14.0
- value
- 59.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 70
- title
- Female
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 98
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 76
- group Id
- BG001
- value
- 70
- group Id
- BG002
- value
- 146
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 11
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 98
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age > 60 years
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 72
- group Id
- BG002
- value
- 137
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 28
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- 3+
- description
- The ECOG measures level of functioning in terms of daily living abilities: 0-Fully active, able to carry on all pre-disease performance without restriction 1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work 2. Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about \>50% of waking hours 3. Capable of only limited selfcare; confined to bed or chair \>50% of waking hours 4. Completely disabled; cannot carry on any selfcare; totally confined to bed or chair 5. Dead
- param Type
- COUNT_OF_PARTICIPANTS
- title
- The Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 81
- title
- Essential thrombocythemia (ET)
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 44
- group Id
- BG002
- value
- 87
- title
- Polycythemia Vera (PV)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Disease Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 46
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Previous Thrombosis
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Previous Hemorrhage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 11
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Splenomegaly
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0
- upper Limit
- 41.7
- value
- 2.6
- group Id
- BG001
- lower Limit
- 0
- upper Limit
- 84.2
- value
- 3.0
- group Id
- BG002
- lower Limit
- 0
- upper Limit
- 84.2
- value
- 2.8
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Disease Duration
- unit Of Measure
- months
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 168
- units
- Participants
- groups
- description
- The subject received the PEGASYS at a dose level of 45 micrograms weekly and gradually increased to the maximum dose of 180 micrograms per week. The dose was administered by prefilled syringes and injected subcutaneously. Subjects received therapy for up to 12 months. Aspirin: Subject asked to take 81 to 100mg per day for the 12 months of the study treatment.
- id
- BG000
- title
- PEGASYS
- description
- Subjects received a 500mg tablet to be taken twice daily for up to 12 months of treatment. Aspirin: Subject asked to take 81 to 100mg per day for the 12 months of the study treatment.
- id
- BG001
- title
- Hydroxyurea
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 14.8
- value
- 56.8
- group Id
- BG001
- spread
- 12.8
- value
- 61.8
- group Id
- BG002
- spread
- 14.0
- value
- 59.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 70
- title
- Female
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 98
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 76
- group Id
- BG001
- value
- 70
- group Id
- BG002
- value
- 146
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 11
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 98
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age > 60 years
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 72
- group Id
- BG002
- value
- 137
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 28
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- 3+
- description
- The ECOG measures level of functioning in terms of daily living abilities: 0-Fully active, able to carry on all pre-disease performance without restriction 1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg.light house work 2. Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about \>50% of waking hours 3. Capable of only limited selfcare; confined to bed or chair \>50% of waking hours 4. Completely disabled; cannot carry on any selfcare; totally confined to bed or chair 5. Dead
- param Type
- COUNT_OF_PARTICIPANTS
- title
- The Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 81
- title
- Essential thrombocythemia (ET)
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 44
- group Id
- BG002
- value
- 87
- title
- Polycythemia Vera (PV)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Disease Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 46
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Previous Thrombosis
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Previous Hemorrhage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 11
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Splenomegaly
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0
- upper Limit
- 41.7
- value
- 2.6
- group Id
- BG001
- lower Limit
- 0
- upper Limit
- 84.2
- value
- 3.0
- group Id
- BG002
- lower Limit
- 0
- upper Limit
- 84.2
- value
- 2.8
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Disease Duration
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle